Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting Pharmaceutical Investing
G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer Biotech Investing
Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership Biotech Investing
Xanthic Biopharma Inc. Commends The U.S. Federal Government’s Promise To Protect States That Have Legalized Cannabis Cannabis Investing News
Progressive Care Reports 20% Increase in Year over Year Prescriptions Filled During March 2018 Pharmaceutical Investing
Liver Biopsy Data from POISE Phase 3 Substudy Supports Obeticholic Acid’s Ability to Reverse or Stabilize Fibrosis and Cirrhosis in Primary Biliary Cholangitis (PBC) Patients Pharmaceutical Investing
Catalyst Biosciences Announces Korean Ministry of Food and Drug Safety Approves Addition of Sixth Cohort to the Phase 1/2 Trial of CB 2679d/ISU304 Pharmaceutical Investing
EyePoint Pharmaceuticals Strengthens Global IP with Notices of Allowance for Two U.S. Patents Related to DEXYCU™ Pharmaceutical Investing
Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries Pharmaceutical Investing
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
